Kinnate Biopharma Management
Management criteria checks 2/4
Kinnate Biopharma's CEO is Nima Farzan, appointed in Mar 2020, has a tenure of 4.08 years. total yearly compensation is $4.54M, comprised of 13.4% salary and 86.6% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth €5.35K. The average tenure of the management team and the board of directors is 3.9 years and 4 years respectively.
Key information
Nima Farzan
Chief executive officer
US$4.5m
Total compensation
| CEO salary percentage | 13.4% |
| CEO tenure | 4.1yrs |
| CEO ownership | 0.005% |
| Management average tenure | 3.9yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$5m | US$608k | -US$113m |
| Sep 30 2023 | n/a | n/a | -US$127m |
| Jun 30 2023 | n/a | n/a | -US$127m |
| Mar 31 2023 | n/a | n/a | -US$122m |
| Dec 31 2022 | US$4m | US$583k | -US$116m |
| Sep 30 2022 | n/a | n/a | -US$111m |
| Jun 30 2022 | n/a | n/a | -US$105m |
| Mar 31 2022 | n/a | n/a | -US$99m |
| Dec 31 2021 | US$8m | US$558k | -US$90m |
| Sep 30 2021 | n/a | n/a | -US$77m |
| Jun 30 2021 | n/a | n/a | -US$63m |
| Mar 31 2021 | n/a | n/a | -US$49m |
| Dec 31 2020 | US$5m | US$359k | -US$36m |
Compensation vs Market: Nima's total compensation ($USD4.54M) is above average for companies of similar size in the German market ($USD388.36K).
Compensation vs Earnings: Nima's compensation has increased whilst the company is unprofitable.
CEO
Nima Farzan (47 yo)
4.1yrs
Tenure
US$4,539,776
Compensation
Mr. Nima Farzan, M.B.A., serves as President and Chief Executive Officer at Kinnate Biopharma Inc. and as a Member of Board of Directors since March 2020. Mr. Farzan had been the Chief Executive Officer at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.1yrs | US$4.54m | 0.0046% € 5.3k | |
| COO, General Counsel | 4yrs | US$1.70m | 0.025% € 29.2k | |
| CFO, Principal Accounting Officer and Executive VP of Corporate Development | 2.8yrs | US$2.88m | 0.046% € 53.6k | |
| Senior Vice President of Research | 3.8yrs | no data | no data |
3.9yrs
Average Tenure
47yo
Average Age
Experienced Management: 6KB's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.1yrs | US$4.54m | 0.0046% € 5.3k | |
| Independent Director | 4.3yrs | US$107.78k | 0% € 0 | |
| Independent Director | 3.8yrs | no data | 0% € 0 | |
| Independent Chair | 3.7yrs | US$139.28k | 0% € 0 | |
| Independent Director | 3.7yrs | US$99.28k | 0% € 0 | |
| Independent Director | 3.5yrs | US$110.28k | 0% € 0 | |
| Member of Scientific Advisory Board & Independent Director | 4.3yrs | US$103.28k | 0.14% € 162.4k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.3yrs | no data | 0% € 0 |
4.0yrs
Average Tenure
52yo
Average Age
Experienced Board: 6KB's board of directors are considered experienced (4 years average tenure).